Liraglutide improves nonalcoholic fatty liver disease by regulation of sestrin2-mediated activation of AMPK/Nrf2/HO-1 pathway in obese mice

DIABETOLOGIA(2019)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要